Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.04%
#2 Audiera Audiera +19.20%
#3 Geodnet Geodnet +14.31%
#4 Ocean Protocol Ocean Protocol +11.36%
#5 Rollbit Coin Rollbit Coin +7.00%
#6 The Bitcoin Bull The Bitcoin Bull +6.81%
#7 Quack AI Quack AI +6.35%
#8 Tutorial Tutorial +5.97%
#9 LAB LAB +5.44%
#10 Bityuan Bityuan +4.83%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Clasificación en acciones #32327
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Precio por acción
$0.88
Última sincronización: 2026-08-17
Capitalización bursátil
$10.41M
Cambio (1 día)
-7.26%
Cambio (1 año)
-50.56%
País
SG
Comercio CytoMed Therapeutics Limited (GDTC)

Categoría

Healthcare
Historial del precio de la acción de CytoMed Therapeutics Limited (GDTC)
Precio más alto de cierre: $0.84 el 2026-08-01

Precio más bajo de cierre: $3.48 el 2023-04-01
Historial del precio de la acción de CytoMed Therapeutics Limited desde 2023 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -14.06%
2025 -41.13%
2024 -30.38%
2023 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.24 -36.86%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.05K -7.55%
KR